Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad M Mohiuddin

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Transplantation|February 18, 2004
Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to toleranceHaruko Ogawa, Muhammad M Mohiuddin, Deng-Ping Yin, et al.
Artificial Organs|June 19, 2023
Partial heart xenotransplantation: A research protocol in non-human primatesTaufiek Konrad Rajab, Corbin E Goerlich, Joseph M Forbess, et al.
Xenotransplantation|January 10, 2022
An intrinsic link to an extrinsic cause of cardiac xenograft growth after xenotransplantation: Commentary (in response to): Zaman, R. et al. Selective loss of resident macrophage-derived insulin-like growth factor-1 abolishes adaptive cardiac growth to stress. Immunity 54, 2057-2071.e6 (2021).: Commentary (in response to): Zaman, R. et al. Selective loss of resident macrophage-derived insulin-like growth factor-1 abolishes adaptive cardiac growth to stress. Immunity 54, 2057-2071.e6 (2021)Corbin E Goerlich, Avneesh Singh, John A Treffalls, et al.
Transplantation|December 30, 2022
CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for TransplantationAvneesh K Singh, Corbin E Goerlich, Tianshu Zhang, et al.
Expert Review of Cardiovascular Therapy|July 12, 2022
Recent advances in porcine cardiac xenotransplantation: from aortic valve replacement to heart transplantationSam Kavarana, Jennie H Kwon, Kasparas Zilinskas, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 28, 2021
The growth of xenotransplanted hearts can be reduced with growth hormone receptor knockout pig donorsCorbin E Goerlich, Bartley Griffith, Peter Hanna, et al.
Clinical Transplantation|June 30, 2018
Consideration of appropriate clinical applications for cardiac xenotransplantationJoshua L Chan, Justin G Miller, Avneesh K Singh, et al.
Xenotransplantation|August 3, 2007
Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation modelCynthia M Porter, Judith A Horvath-Arcidiacono, Avneesh K Singh, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 8, 2014
Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantationMuhammad M Mohiuddin, Avneesh K Singh, Philip C Corcoran, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 11, 2022
Cardiac Xenotransplantation: Progress in Preclinical Models and Prospects for Clinical TranslationAvneesh K Singh, Corbin E Goerlich, Aakash M Shah, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Transplantation|February 18, 2004
Mouse-heart grafts expressing an incompatible carbohydrate antigen. II. Transition from accommodation to toleranceHaruko Ogawa, Muhammad M Mohiuddin, Deng-Ping Yin, et al.
Artificial Organs|June 19, 2023
Partial heart xenotransplantation: A research protocol in non-human primatesTaufiek Konrad Rajab, Corbin E Goerlich, Joseph M Forbess, et al.
Xenotransplantation|January 10, 2022
An intrinsic link to an extrinsic cause of cardiac xenograft growth after xenotransplantation: Commentary (in response to): Zaman, R. et al. Selective loss of resident macrophage-derived insulin-like growth factor-1 abolishes adaptive cardiac growth to stress. Immunity 54, 2057-2071.e6 (2021).: Commentary (in response to): Zaman, R. et al. Selective loss of resident macrophage-derived insulin-like growth factor-1 abolishes adaptive cardiac growth to stress. Immunity 54, 2057-2071.e6 (2021)Corbin E Goerlich, Avneesh Singh, John A Treffalls, et al.
Transplantation|December 30, 2022
CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for TransplantationAvneesh K Singh, Corbin E Goerlich, Tianshu Zhang, et al.
Expert Review of Cardiovascular Therapy|July 12, 2022
Recent advances in porcine cardiac xenotransplantation: from aortic valve replacement to heart transplantationSam Kavarana, Jennie H Kwon, Kasparas Zilinskas, et al.
The Journal of Thoracic and Cardiovascular Surgery|September 28, 2021
The growth of xenotransplanted hearts can be reduced with growth hormone receptor knockout pig donorsCorbin E Goerlich, Bartley Griffith, Peter Hanna, et al.
Clinical Transplantation|June 30, 2018
Consideration of appropriate clinical applications for cardiac xenotransplantationJoshua L Chan, Justin G Miller, Avneesh K Singh, et al.
Xenotransplantation|August 3, 2007
Characterization and expansion of baboon CD4+CD25+ Treg cells for potential use in a non-human primate xenotransplantation modelCynthia M Porter, Judith A Horvath-Arcidiacono, Avneesh K Singh, et al.
The Journal of Thoracic and Cardiovascular Surgery|July 8, 2014
Genetically engineered pigs and target-specific immunomodulation provide significant graft survival and hope for clinical cardiac xenotransplantationMuhammad M Mohiuddin, Avneesh K Singh, Philip C Corcoran, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|April 11, 2022
Cardiac Xenotransplantation: Progress in Preclinical Models and Prospects for Clinical TranslationAvneesh K Singh, Corbin E Goerlich, Aakash M Shah, et al.
Pageof 7